Neogen (NEOG) Income from Continuing Operations (2010 - 2026)
Neogen's (NEOG) quarterly Income from Continuing Operations came in at 17000000.0 in Q1 2026, down 55.96% year-on-year from 38604166.67 in Q1 2025, and down 6.76% quarter-over-quarter from 15924000.0 in Q4 2025.
Neogen (NEOG) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Neogen's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 17000000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 55.96% year-over-year to 17000000.0 in Q1 2026; TTM through Feb 2026 was 648025000.0, a 33.56% decrease from a year earlier, with the FY2025 full-year figure at 1131239000.0, down 11907.63% from the prior year.
- Income from Continuing Operations declined to 17000000.0 in Q1 2026 per NEOG's latest filing, from 15924000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 36338000.0 in Q3 2025 and bottomed at 651439000.0 in Q2 2025.
- The 5-year median for Income from Continuing Operations is 3487000.0 (2023), against an average of 67037529.41.
- Across the five-year window, Income from Continuing Operations tumbled 12985.23% in 2024 and soared 388.19% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 41841000.0 in 2022, then surged by 91.67% to 3487000.0 in 2023, then tumbled by 12985.23% to 456282000.0 in 2024, then soared by 96.51% to 15924000.0 in 2025, then fell by 6.76% to 17000000.0 in 2026.
- Per Business Quant, the three latest NEOG Income from Continuing Operations figures stand at 17000000.0 (Q1 2026), 15924000.0 (Q4 2025), and 36338000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | -17.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -17.00 Mn |
| Nov 30, 2025 | -15.92 Mn |
| Aug 31, 2025 | 36.34 Mn |
| May 31, 2025 | -651.44 Mn |
| Feb 28, 2025 | -10.90 Mn |
| Nov 30, 2024 | -456.28 Mn |
| Aug 31, 2024 | -12.61 Mn |
| May 31, 2024 | -5.42 Mn |
| Feb 29, 2024 | -2.02 Mn |
| Nov 30, 2023 | -3.49 Mn |
| Aug 31, 2023 | 1.50 Mn |
| May 31, 2023 | 6.38 Mn |
| Feb 28, 2023 | 8.19 Mn |
| Nov 30, 2022 | -41.84 Mn |
| Aug 31, 2022 | 5.21 Mn |
| May 31, 2022 | 14.22 Mn |
| Feb 28, 2022 | 5.44 Mn |
| Nov 30, 2021 | 10.83 Mn |
| Aug 31, 2021 | 17.08 Mn |
| May 31, 2021 | 14.34 Mn |